Table 1.
Factors | RNA-seq (N = 190) |
---|---|
N (%) | |
Age | |
Median (min, max) | 54 (29, 90) |
Menopausal status Pre | 38 (20%) |
Peri | 10 (5%) |
Post | 117 (62%) |
Indeterminate | 11 (6%) |
Unknown | 14 (7%) |
Race White | 111 (58%) |
Black | 64 (34%) |
Asian | 7 (4%) |
Unknown | 8 (4%) |
T stage | |
T1 | 37 (19%) |
T2 | 127 (67%) |
T3 | 19 (10%) |
T4 | 6 (3%) |
Unknown | 1 (1%) |
N stage | |
N0 | 118 (62%) |
N1 | 51 (27%) |
N2 | 15 (8%) |
N3 | 6 (3%) |
M stage | |
M0 | 165 (87%) |
M1 | 4 (2%) |
Unknown | 21 (11%) |
ER | |
Positive | 21 (11%) |
Negative | 162 (85%) |
Unknown | 7 (4%) |
PR | |
Positive | 12 (6%) |
Negative | 169 (89%) |
Unknown | 9 (5%) |
HER2 | |
Positive | 6 (3%) |
Negative | 180 (95%) |
Unknown | 4 (2%) |
DFI | |
Event | 22 (12%) |
Event-free | 148 (78%) |
Unknown | 20 (10%) |
PFI | |
Event | 29 (15%) |
Event-free | 161 (85%) |